The use of donor and recipient screening for toxoplasma in the era of universal trimethoprim sulfamethoxazole prophylaxis

Transplantation

Volumn 85, Issue 7, 2008, Pages 980-985

  Gourishankar, Sita ^a   Doucette, Karen ^a   Fenton, Jayne ^a   Purych, Dale ^a   Kowalewska Grochowska, Kinga ^a   Preiksaitis, Jutta ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Prophylaxis; Solid organ transplantation; Toxoplasmosis

Indexed keywords

COTRIMOXAZOLE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CHILD; COHORT ANALYSIS; DONOR SELECTION; FEMALE; GRAFT INFECTION; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; INFECTION PREVENTION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING TEST; SEROCONVERSION; SEROPREVALENCE; TOXOPLASMOSIS;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTI-INFECTIVE AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HEART TRANSPLANTATION; HEART-LUNG TRANSPLANTATION; HUMANS; INFANT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MASS SCREENING; MIDDLE AGED; PANCREAS TRANSPLANTATION; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TISSUE DONORS; TOXOPLASMA; TOXOPLASMOSIS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 42149193664     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318169bebd     Document Type: Article

References (42)

1. Bowie WR, King AS, Werker DH, et al. Outbreak of toxoplasmosis associated with municipal drinking water. The BC Toxoplasma Investigation Team. Lancet 1997; 350: 173.
2. Montoya J, Kovacs J, Remington JS. Toxoplasma gondii. In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and practice of infectious diseases, vol. 2 [ed. 6]. Philadelphia, PA, Elsevier Churchill Livingstone 2005, p 3170.
3. Krick JA, Remington JS. Toxoplasmosis in the adult - an overview. N Engl J Med 1978; 298: 550.
4. Hakim M, Esmore D, Wallwork J, et al. Toxoplasmosis in cardiac transplantation. BMJ (Clin Res Ed) 1986; 292: 1108.
5. Carey RM, Kimball AC, Armstrong D, et al. Toxoplasmosis. Clinical experiences in a cancer hospital. Am J Med 1973; 54: 30.
6. Ruskin J, Remington JS. Toxoplasmosis in the compromised host. Ann Intern Med 1976; 84: 193.
7. Remington JS. Toxoplasmosis in the adult. Bull NY Acad Med 1974; 50: 211.
8. Luft BJ, Naot Y, Araujo FG, et al. Primary and reactivated toxoplasma infection in patients with cardiac transplants. Clinical spectrum and problems in diagnosis in a defined population. Ann Intern Med 1983; 99: 27.
9. Wreghitt TG, Hakim M, Gray JJ, et al. Toxoplasmosis in heart and heart and lung transplant recipients. J Clin Pathol 1989; 42: 194.
10. Nagington J, Martin AL. Toxoplasmosis and heart transplantation. Lancet 1983; 2: 679.
11. Stinson EB, Bieber CP, Griepp RB, et al. Infectious complications after cardiac transplantation in man. Ann Intern Med 1971; 74: 22.
12. McLeod R, Berry PF, Marshall WH Jr, et al. Toxoplasmosis presenting as brain abscesses. Diagnosis by computerized tomography and cytology of aspirated purulent material. Am J Med 1979; 67: 711.
13. Britt RH, Enzmann DR, Remington JS. Intracranial infection in cardiac transplant recipients. Ann Neurol 1981; 9: 107.
14. Rose AG, Uys CJ, Novitsky D, et al. Toxoplasmosis of donor and recipient hearts after heterotopic cardiac transplantation. Arch Pathol Lab Med 1983; 107: 368.
15. Hakim M, Wreghitt TG, English TA, et al. Significance of donor transmitted disease in cardiac transplantation. J Heart Transplant 1985; 4: 302.
16. Montero CG, Martinez AJ. Neuropathology of heart transplantation: 23 cases. Neurology 1986; 36: 1149.
17. Holliman RE, Johnson J, Burke M, et al. False-negative dye-test findings in a case of fatal toxoplasmosis associated with cardiac transplantation. J Infect 1990; 21: 185.
18. Reynolds ES, Walls KW, Pfeiffer RI. Generalized toxoplasmosis following renal transplantation. Report of a case. Arch Intern Med 1966; 118: 401.
19. Kusne S, Dummer JS, Ho M, et al. Self-limited Toxoplasma parasitemia after liver transplantation. Transplantation 1987; 44: 457.
20. Ryning FW, McLeod R, Maddox JC, et al. Probable transmission of Toxoplasma gondii by organ transplantation. Ann Intern Med 1979; 90: 47.
21. Lappalainen M, Jokiranta TS, Halme L, et al. Disseminated toxoplasmosis after liver transplantation: Case report and review. Clin Infect Dis 1998; 27: 1327.
22. Anthony CW. Disseminated toxoplasmosis in a liver transplant patient. J Am Med Womens Assoc 1972; 27: 601.
23. Mayes JT, O'Connor BJ, Avery R, et al. Transmission of Toxoplasma gondii infection by liver transplantation. Clin Infect Dis 1995; 21: 511.
24. Munir A, Zaman M, Eltorky M. Toxoplasma gondii pneumonia in a pancreas transplant patient. South Med J 2000; 93: 614.
25. Mason JC, Ordelheide KS, Grames GM, et al. Toxoplasmosis in two renal transplant recipients from a single donor. Transplantation 1987; 44: 588.
26. Herb HM, Jontofsohn R, Loffler HD, et al. Toxoplasmosis after renal transplantation. Clin Nephrol 1977; 8: 529.
27. Sluiters JF, Balk AH, Essed CE, et al. Indirect enzyme-linked immunosorbent assay for immunoglobulin G and four immunoassays for immunoglobulin M to Toxoplasma gondii in a series of heart transplant recipients. J Clin Microbiol 1989; 27: 529.
28. Weigel HM, de Vries E, Regez RM, et al. Cotrimoxazole is effective as primary prophylaxis for toxoplasmic encephalitis in HIV-infected patients: A case control study. Scand J Infect Dis 1997; 29: 499.
29. Carr A, Tindall B, Brew BJ, et al. Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Intern Med 1992; 117: 106.
30. Keating MR, Wilhelm MP, Walker RC. Strategies for prevention of infection after cardiac transplantation. Mayo Clin Proc 1992; 67: 676.
31. Keogh A, Macdonald P, Richens D, et al. Mini-dose trimethoprim with sulphamethoxazole prevents pneumocystis and toxoplasmosis infections after heart transplantation. Transplant Proc 1992; 24: 2263.
32. Munoz P, Arencibia J, Rodriguez C, et al. Trimethoprim-sulfamethoxazole as toxoplasmosis prophylaxis for heart transplant recipients. Clin Infect Dis 2003; 36: 932, author reply 933.
33. Baden LR, Katz JT, Franck L, et al. Successful toxoplasmosis prophylaxis after orthotopic cardiac transplantation with trimethoprim-sulfamethoxazole. Transplantation 2003; 75: 339.
34. Orr KE, Gould FK, Short G, et al. Outcome of Toxoplasma gondii mismatches in heart transplant recipients over a period of 8 years. J Infect 1994; 29: 249.
35. Wreghitt TG, Gray JJ, Pavel P, et al. Efficacy of pyrimethamine for the prevention of donor-acquired Toxoplasma gondii infection in heart and heart-lung transplant patients. Transpl Int 1992; 5: 197.
36. Soave R. Prophylaxis strategies for solid-organ transplantation. Clin Infect Dis 2001;33(suppl 1):S26.
37. Smith KL, Wilson M, Hightower AW, et al. Prevalence of Toxoplasma gondii antibodies in US military recruits in 1989: Comparison with data published in 1965. Clin Infect Dis 1996; 23: 1182.
38. Walker J, Nokes DJ, Jennings R. Longitudinal study of Toxoplasma seroprevalence in South Yorkshire. Epidemiol Infect 1992; 108: 99.
39. Joynson DH. Epidemiology of toxoplasmosis in the U.K. Scand J Infect Dis Suppl 1992; 84: 65.
40. Port FK, Dykstra DM, Merion RM, et al. Trends and results for organ donation and transplantation in the United States, 2004. Am J Transplant 2005; 5: 843.
41. NCCLS. NCCLS standard M36-A, vol. 24, no. 6: Clinical use and interpretation of serological tests for Toxoplasma gondii: Approved guideline. Wayne, PA, NCCLS 2004.
42. Guidelines for the prevention and management of infectious complications of solid organ transplantation. Am J Transplant 2004; 4(suppl 10): 51.